Cambridge, MA, May 5, 2014 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the Human Proteome Organization (HUPO) are delighted to announce HUPO's affiliation with Elsevier's new, open access journal, Translational Proteomics.
HUPO is an international scientific organization that represents and promotes proteomics through worldwide cooperation and collaborations. HUPO plays an essential role in the development and implementation of standards and policies in proteomics research as well as determining how proteins play a role in human health and disease.
As such, Elsevier is delighted that its open access journal Translational Proteomics can fill an important need for the organization helping them with the dissemination of translational discoveries.
Translational Proteomics covers all areas of human proteomics using multi-disciplinary approaches to untangle complex disease processes. The journal emphasizes linking basic proteomic sciences to clinical research, from patient to bench to bedside, an important component of proteomics research that the HUPO embraces.
"HUPO is very pleased to provide its membership with significant benefits from this new collaboration with Translational Proteomics and Elsevier and we look forward to a long and fruitful relationship," explains Maxey C.M. Chung, HUPO Secretary General.
"We are really excited about this new collaboration with HUPO", says Jean-Charles Sanchez, Editor-in-Chief of Translational Proteomics. "Both HUPO and Translational Proteomics aim to cover and disseminate knowledge across all areas of human proteomics using multi-disciplinary approaches to untangle complex disease processes. The journal provides space for publications of the Biology/Disease Human Proteome Project (HPP) initiatives."
Elsevier will also annually sponsor the 'HUPO Translationa
|Contact: Paige Shaklee|